Cargando…
Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233357/ https://www.ncbi.nlm.nih.gov/pubmed/35752767 http://dx.doi.org/10.1186/s12885-022-09752-5 |
_version_ | 1784735746022703104 |
---|---|
author | Ruan, Guo-Tian Xie, Hai-Lun Gong, Yi-Zhen Ge, Yi-Zhong Zhang, Qi Wang, Zi-Wen Zhang, Xi Zhang, He-Yang Tang, Meng Song, Meng-Meng Zhang, Xiao-Wei Yang, Ming Chen, Yong-Bing Yu, Kai-Ying Deng, Li Wang, Kun-Hua Cong, Ming-Hua Shi, Han-Ping |
author_facet | Ruan, Guo-Tian Xie, Hai-Lun Gong, Yi-Zhen Ge, Yi-Zhong Zhang, Qi Wang, Zi-Wen Zhang, Xi Zhang, He-Yang Tang, Meng Song, Meng-Meng Zhang, Xiao-Wei Yang, Ming Chen, Yong-Bing Yu, Kai-Ying Deng, Li Wang, Kun-Hua Cong, Ming-Hua Shi, Han-Ping |
author_sort | Ruan, Guo-Tian |
collection | PubMed |
description | BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221 patients with cancer, with a mean age of 59.41±11.15 years, of whom 3,061 (58.6%) were male. The surrogate IR indices included low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LHR) ratio, total cholesterol to high-density lipoprotein cholesterol (TC/ HDL-c) ratio, triglyceride to high-density lipoprotein cholesterol (TG/HDL-c) ratio, and fasting triglyceride glucose (TyG). Prognostic receiver operator characteristic (ROC) curves and C-indices were used to select a better surrogate IR index in patients with cancer. The prognostic value of the indicators was evaluated using univariate and multivariate survival analyses. RESULTS: In this study, the median survival time of patients was 44.5 (40.5–51.4) months, and the overall mortality in the 12-month period was 1,115 (53.7%), with 196 mortality events per 1,000 patient-years of patients’ follow-up. The prognostic ROC curve and C-index suggested that the prognostic value of LHR was better than that of the other IR indices. The multivariate-adjusted hazard ratios (HRs) for overall survival (OS) were higher in patients with high C-reactive protein (CRP) (HR, 1.51; 95% confidence interval [CI]: 1.38–1.65) and high LHR (HR, 1.20; 95% CI: 1.06–1.37), respectively. The mortality rate of patients with both high CRP and LHR was 1.75-fold higher than that of patients with both low CRP and LHR. CONCLUSION: Both CRP and LHR showed good survival predictions in patients with cancer. CRP combined with LHR can improve the predictive power of patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09752-5. |
format | Online Article Text |
id | pubmed-9233357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92333572022-06-26 Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study Ruan, Guo-Tian Xie, Hai-Lun Gong, Yi-Zhen Ge, Yi-Zhong Zhang, Qi Wang, Zi-Wen Zhang, Xi Zhang, He-Yang Tang, Meng Song, Meng-Meng Zhang, Xiao-Wei Yang, Ming Chen, Yong-Bing Yu, Kai-Ying Deng, Li Wang, Kun-Hua Cong, Ming-Hua Shi, Han-Ping BMC Cancer Research BACKGROUND: Systemic inflammation and insulin resistance (IR) are often associated with poor prognosis in cancer. This study aimed to investigate the prognostic value of surrogate systemic inflammation and IR indices in patients with cancer. METHODS: This multicenter prospective study included 5,221 patients with cancer, with a mean age of 59.41±11.15 years, of whom 3,061 (58.6%) were male. The surrogate IR indices included low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LHR) ratio, total cholesterol to high-density lipoprotein cholesterol (TC/ HDL-c) ratio, triglyceride to high-density lipoprotein cholesterol (TG/HDL-c) ratio, and fasting triglyceride glucose (TyG). Prognostic receiver operator characteristic (ROC) curves and C-indices were used to select a better surrogate IR index in patients with cancer. The prognostic value of the indicators was evaluated using univariate and multivariate survival analyses. RESULTS: In this study, the median survival time of patients was 44.5 (40.5–51.4) months, and the overall mortality in the 12-month period was 1,115 (53.7%), with 196 mortality events per 1,000 patient-years of patients’ follow-up. The prognostic ROC curve and C-index suggested that the prognostic value of LHR was better than that of the other IR indices. The multivariate-adjusted hazard ratios (HRs) for overall survival (OS) were higher in patients with high C-reactive protein (CRP) (HR, 1.51; 95% confidence interval [CI]: 1.38–1.65) and high LHR (HR, 1.20; 95% CI: 1.06–1.37), respectively. The mortality rate of patients with both high CRP and LHR was 1.75-fold higher than that of patients with both low CRP and LHR. CONCLUSION: Both CRP and LHR showed good survival predictions in patients with cancer. CRP combined with LHR can improve the predictive power of patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09752-5. BioMed Central 2022-06-25 /pmc/articles/PMC9233357/ /pubmed/35752767 http://dx.doi.org/10.1186/s12885-022-09752-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ruan, Guo-Tian Xie, Hai-Lun Gong, Yi-Zhen Ge, Yi-Zhong Zhang, Qi Wang, Zi-Wen Zhang, Xi Zhang, He-Yang Tang, Meng Song, Meng-Meng Zhang, Xiao-Wei Yang, Ming Chen, Yong-Bing Yu, Kai-Ying Deng, Li Wang, Kun-Hua Cong, Ming-Hua Shi, Han-Ping Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title | Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title_full | Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title_fullStr | Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title_full_unstemmed | Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title_short | Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
title_sort | prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233357/ https://www.ncbi.nlm.nih.gov/pubmed/35752767 http://dx.doi.org/10.1186/s12885-022-09752-5 |
work_keys_str_mv | AT ruanguotian prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT xiehailun prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT gongyizhen prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT geyizhong prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT zhangqi prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT wangziwen prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT zhangxi prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT zhangheyang prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT tangmeng prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT songmengmeng prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT zhangxiaowei prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT yangming prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT chenyongbing prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT yukaiying prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT dengli prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT wangkunhua prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT congminghua prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy AT shihanping prognosticimportanceofsystemicinflammationandinsulinresistanceinpatientswithcanceraprospectivemulticenterstudy |